LC-MS/MS comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-10-24. Where a claim depends on a specific study, the study is described rather than over-claimed.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human use | Investigational status in most countries |
| Sports status | Prohibited by WADA | Classified as non-approved or metabolic modulator |
| Common analytical method | LC-MS/MS | Used for trace detection in biological samples |
| Typical test matrices | Urine and blood | Sample choice depends on testing program |
| Human trial data | None published | Effects and safety are not established |
Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.
The mechanism of action involves binding to REV-ERB receptors and recruiting corepressor complexes, which represses target gene transcription. This contrasts with many nuclear receptor agonists that activate transcription. Downstream effects may include changes in autophagy, mitochondrial biogenesis, and lipid handling, but the precise pathways remain an active area of study. Whether these molecular events translate into meaningful physiological effects in humans is unresolved. Most evidence comes from cultured cells and rodent models rather than human participants.
SR9009 is a synthetic small molecule developed as an agonist of the nuclear receptors REV-ERBα (NR1D1) and REV-ERBβ (NR1D2). These receptors help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, SR9009 alters transcription of genes involved in lipid metabolism, inflammation, and mitochondrial function. It is not an approved medicine, and its pharmacological profile in humans remains largely uncharacterized. The compound is frequently discussed in the context of circadian biology and metabolic research rather than clinical use.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
== Heterocyclic amines and neurological disorders == Harmane, a β-carboline alkaloid found in meats is "highly tremorogenic" (tremor inducing). While harmane has been found in roughly 50% higher concentrations in patients with essential tremor than in controls, there is no direct correlation between blood-levels and levels of daily meat consumption, suggesting a difference in metabolism of this chemical plays a greater role. These chemicals are formed during the cooking process of meat, particularly the longer they are cooked, and the more they are exposed to high temperatures during cooking.
In 66 AD, the Roman tribune Neapolitanus met with King Agrippa II in Iamnia, to inform him of his mission to investigate the situation in Jerusalem, following Florus' seizure of Temple funds and clashes between Jews and Roman troops. Later, in spring 68 AD, after the Roman army under Vespasian quelled the insurrection in Galilee, the army marched upon Iamnia and Azotus, taking both towns and stationing garrisons within them. Following the failure of the revolt and the destruction of the Second Temple, Judaism underwent significant reform in Yavne. According to rabbinic tradition, Rabbi Yohanan ben Zakkai and his disciples were permitted to settle in Iamnia during the outbreak of the war, after ben Zakkai, realizing that Jerusalem was about to fall, departed the city and sought the permission of Vespasian, commander of the Roman forces, to settle in Yavne and teach his disciples. Upon the fall of Jerusalem, his school functioned as a Sanhedrin. It was also theorized for some time to have been the site of a supposed Council of Jamnia that established the rabbinic Jewish biblical canon (although current scholarship largely rejects the theory that such a council in fact occurred). According to the Jerusalem Talmud (Berakhot 1:4), when the rabbis argued over some fine point of Jewish law, a Divine voice (Hebrew: bat ḳol) was heard in Yavne, ruling in favor of the School of Hillel.
== Mechanism == The current believed mechanism for synthetase activity is that first glutathione and Mg2+-ATP bind to the enzyme in a ternary complex where glutathione becomes activated by ATP and forms glutathionyl phosphate. ADP then leaves the active site and the activated phosphate still bound to the enzyme in what is equivalent to a substituted enzyme reacts with glutathionylspermidine to form trypanothione.
Sources: en.wikipedia.org
A think tank or public policy institute is an organization that performs research and advocacy concerning topics such as social policy, political strategy, economics, military, technology, and culture. Most think tanks are non-governmental organizations, but some are semi-autonomous agencies within a government, and some are associated with particular political parties, businesses, or the military. Think tanks are often funded by individual donations, with many also accepting government grants. Think tanks publish articles and studies, and sometimes draft legislation on particular matters of policy or society. This information is then used by governments, businesses, media organizations, social movements, or other interest groups. Think tanks range from those associated with highly academic or scholarly activities to those that are overtly ideological and pushing for particular policies, with a wide range among them in terms of the quality of their research. Later generations of think tanks have tended to be more ideologically oriented.
This led to the 2008 Andean diplomatic crisis between Colombia and Ecuadorian President Rafael Correa, supported by Venezuelan President Hugo Chávez. On March 3, Iván Ríos, also a member of the FARC Central High Command was killed by his security chief, "Rojas". In March 2008 alone, FARC lost 3 members of their Secretariat, including their founder. On May 24, 2008, Colombian magazine, Revista Semana, published an interview with Colombian Defense Minister Juan Manuel Santos in which Santos mentioned the death of Manuel Marulanda Vélez. The news was confirmed by FARC-commander "Timochenko" on Venezuelan-based television station Telesur on May 25, 2008. "Timochenko" announced the new commander in chief as "Alfonso Cano". In May 2008, a dozen jailed paramilitary leaders were extradited to the United States on drug-related charges. In 2009, extradited paramilitary leader Salvatore Mancuso would go on to claim that the AUC had supported Uribe's 2002 election, but said it was a result of their similar "ideological discourse" and not the result of any direct prior arrangement. On July 2, 2008, the Colombian armed forces launched Operation Jaque which resulted in the freedom of 15 political hostages, including former Colombian presidential candidate Íngrid Betancourt, Marc Gonsalves, Thomas Howes, and Keith Stansell, three American military contractors employed by Northrop Grumman, and 11 Colombian military and police members. Two FARC members were arrested.
=== Tumors === Th22 cells are involved in tumorigenesis in cases of hepatocellular carcinoma, liposarcoma or colon cancer, and affect tumor tissue in two different pathways. Overexpression of interleukin-22 (IL-22) or Th22 cells may result in the progression of cancer growth and cause malignant epithelial cell proliferation. However, physiological functions of Th22 cells are tissue repair and wound healing. Some studies have shown a possible anti-tumor effect of these cells, and normal interleukin-22 (IL-22) secretion leads to tissue repair.
== Overview == The pub was the home to the Cantabrigensis Hash House Harriers between 1993 and 2017, a rowing club and a cricket team. It was the start/finish venue on the legendary King Street Run. All of these activities and more were encouraged (and in the case of the cricket team, started) by Terry Kavanagh (1937-2012), who was landlord between 1992 and 2009. Since 1992 the St Radegund has played an annual cricket match against The Champion of the Thames, for the King Street Trophy. In 2008, the saga of the 2003 St Radegund cricket tour to Croatia, The Ascent of Mount Hum, was published, to critical acclaim. Friday night is Vera Lynn Appreciation Society night when large amounts of gin and tonics were served along with to Vera Lynn’s songs. In 2007, it was pointed out that the pub sign depicted the arms of the Austrian municipality, Sankt Radegund bei Graz rather than the saint herself. A local artist was commissioned to correct the mistake and the story attracted media comment. In 2010, the new landlord, James Hoskins, reverted to a design incorporating the former (incorrect) arms. In early 2015 the premises underwent a programme of refurbishment and redecoration after which it became a pub tied to the Saffron Brewery, ceasing to serve Habit and Sackcloth, beers specially brewed for the pub by Milton Brewery. It was closed under notice of forfeiture in August 2019. In 2020 Cold Chain Bars obtained the lease and the pub reopened in March 2024 before closing again in October of the same year.
Sources: en.wikipedia.org
No. It is an investigational compound without approved therapeutic indications. It is sold for research purposes only in many jurisdictions.
Sports authorities prohibit it because it is not approved for human use and has potential performance-enhancing effects. It appears on anti-doping lists under non-approved or metabolic modulator categories.
Detection usually uses liquid chromatography-tandem mass spectrometry. The method targets the parent compound or its metabolites in urine or blood.
SR9009 is a synthetic REV-ERB agonist used in laboratory research. It is not an approved drug, and its effects in humans are not well characterized. It is often sold as a research chemical under the name Stenabolic.